Despite a growing interest in impact investment in Africa, driven by public and private financiers and major foundations, the annual growth of 15% over the past five years remains modest compared to over 30% in the United States and Europe. Unfortunately, impact investors in Africa face significant obstacles including currency risk affecting profitability and lack of demand from other investors.
Michael Jermaine Cards is a journalist who writes for Born2Invest, covering a wide range of topics in the business and pharmaceutical industries. With a focus on financial news and investments, Michael provides insightful analysis and reporting on the latest developments in the pharmaceutical sector, including mergers and acquisitions, drug approvals, and market trends.